Induction of pre-transplant Epstein–Barr virus (EBV) infection by donor blood transfusion in EBV–seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases

MLA

Babel, N., et al. “Induction of Pre-Transplant Epstein–Barr Virus (EBV) Infection by Donor Blood Transfusion in EBV–seronegative Recipients May Reduce Risk of Post-Transplant Lymphoproliferative Disease in Adolescent Renal Transplant Patients: Report of Two Cases.” Transplant Infectious Disease, vol. 7, no. 3/4, Sept. 2005, pp. 133–36. EBSCOhost, https://doi.org/10.1111/j.1399-3062.2005.00110.x.

APA

Babel, N., Gabdrakhmanova, L., Hammer, M., Rosenberger, C., Oppert, M., Volk, H.-D., & Reinke, P. (2005). Induction of pre-transplant Epstein–Barr virus (EBV) infection by donor blood transfusion in EBV–seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases. Transplant Infectious Disease, 7(3/4), 133–136. https://doi.org/10.1111/j.1399-3062.2005.00110.x

Chicago

Babel, N., L. Gabdrakhmanova, M. Hammer, C. Rosenberger, M. Oppert, H.-D. Volk, and P. Reinke. 2005. “Induction of Pre-Transplant Epstein–Barr Virus (EBV) Infection by Donor Blood Transfusion in EBV–seronegative Recipients May Reduce Risk of Post-Transplant Lymphoproliferative Disease in Adolescent Renal Transplant Patients: Report of Two Cases.” Transplant Infectious Disease 7 (3/4): 133–36. doi:10.1111/j.1399-3062.2005.00110.x.